Changes in Serum Cytokines May Predict Therapeutic Efficacy of Tofacitinib in Rheumatoid Arthritis

Figure 2

The serum cytokines levels in the RA patients after tofacitinib treatment at the week 0, 4, 8, 12, 16, and 24. (a) IL-35; (b) TNF-α (c) IL-17; (d) IL-6; (e) IFN-γ. Abbreviations: IL: interleukin; TNF: tumor necrosis factor; IFN: interferon. The -axis is the six measurement time points indicated as 0, 4, 8, 12, 16, and 24 weeks after tofacitinib treatment is initiated.

(a)

(b)

(c)

(d)

(e)